Trial intelligence / Profile preview

Kudiezi injection in nonproliferative diabetic retinopathy

ChiCTR-TRC-12002122Phase 4Completed

Sponsor
Hebei Eye Hospital
Start
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of Kudiezi in diabetic retinopathy (DR) (2 arms), sponsored by Hebei Eye Hospital. Primary endpoints: General reaction, Blood routine examination and 9 more. Started Apr 2012; status: completed.

02

Drugs

Kudiezi
03

Conditions

diabetic retinopathy (DR)

Beyond the preview

Go deeper on ChiCTR-TRC-12002122.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002122.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call